| | Sun | Mon | Tue | Wed | Thu |
| (INOR) Bioinorganic: DNA and RNA | A |   |   |   | P |
| (MEDI) Fragment-Based Drug Discovery Cosponsored by Teledyne Isco | A |   |   |   |   |
| (PMSE) Polymer-Directed Mineralization | D | D | A |   |   |
| (PHYS) Biophysics of RNA | D | D | P | A |   |
| (AGRO) Glyphosate-Resistant Crops and Weeds: Present and Future | D | D |   |   |   |
| (COLL) Biological Surface Chemistry Cosponsored by PHYS | D | DE | P | D | D |
| (AGFD) Soluble Cellulose as Dietary Fiber in Human Nutrition and Health | D |   |   |   |   |
| (PMSE) Materials for Probing and Manipulating Living Cells | D |   |   |   |   |
| (INOR) Structural, Functional and Biomimetic Modeling in Bioinorganic Chemistry | P |   | P |   |   |
| (CHAL) The Many Faces of CHAL: Where Chemistry Meets the Law | P |   |   |   |   |
| (MEDI) First Time Disclosure of Clinical Candidates | P |   |   |   |   |
| (INOR) Structural, Functional and Biomimetic Modeling in Bioinorganic Chemistry | E |   | E |   |   |
| (INOR) The Bioinorganic Chemistry Relating to Enzymes and Proteins | E |   |   |   |   |
| (CHAL) Intellectual Property Issues in Solid Forms: Polymorphs, Amorphous Materials, Cocrystals and Beyond |   | A |   |   |   |
| (MEDI) Drugs from Academia: Marketed Drugs Discovered in Academic Labs |   | A |   |   |   |
| (MEDI) Kinesin Spindle Protein Inhibitors |   | A |   |   |   |
| (PMSE) Designed Macromolecular Assemblies for Biomedical Applications |   | D | D | D |   |
| (INOR) Alfred Bader Award in Bioinorganic and Bioorganic Chemistry: Symposium in Honor of Eckard Munck |   | P | A |   |   |
| (CHED) Exploring and Exploiting Nature with Biomimetics Cosponsored by WCC, BIOL, and INOR |   | P | D |   |   |
| (MEDI) Ligands for the Glucocorticoid Receptor |   | P |   |   |   |
| (GEOC) Mechanisms of Metal Binding onto Microbial Cell Walls |   |   | A | A |   |
| (MEDI) Mechanistic Approaches to Increasing High Density Lipoprotein Cholesterol Cosponsored by Wyeth Research |   |   | A |   |   |
| (AGRO) Agricultural Biomass, Biobased Products, and Biofuels Cosponsored by FUEL, SUST, CELL, and CINF |   |   | P | D | D |
| (MEDI) Emerging Targets for the Treatment of Type-2 Diabetes |   |   | P |   |   |
| (INOR) Bioinorganic: DNA and RNA |   |   | E |   |   |
| (ORGN) New Reactions and Methodology, Total Synthesis, Materials, Devices and Switches, Lipids, Nucleotides and Mimetics |   |   | E |   |   |
| (CINF) Advanced Mining and Use of Life Science Information Cosponsored by CSA Trust, BIOT, BTEC, MEDI, and COMP |   |   |   | A |   |
| (CHAL) Ensuring the Effective Patent Protection of Innovative Molecular Technology |   |   |   | A |   |
| (MEDI) E. B. Hershberg Award for Important Discoveries in Medicinally Active Products: Estrogen Receptor Beta Symposium in Honor of John A. Katzenellenbogen Cosponsored by Eli Lilly |   |   |   | A |   |
| (ORGN) Biomimetic Natural and Unnatural Products Synthesis |   |   |   | D |   |
| (MEDI) ACS Award for Team Innovation: New Approaches to Confront Antibacterial Resistance Symposium in Honor of Steven J. Brickner, Michael R. Barbachyn, Douglas K. Hutchinson, and Peter R. Manninen |   |   |   | P |   |
| (MEDI) Medicinal Chemistry of Ion Channels/Voltage-Gated Channels and Pain |   |   |   | P |   |
| (CHAL) The Many Faces of CHAL: Where Chemistry Meets the Law |   |   |   |   | A |
| (INOR) The Bioinorganic Chemistry Relating to Enzymes and Proteins |   |   |   |   | A |
| (CHAL) The Many Faces of CHAL: Where Chemistry Meets the Law |   |   |   |   | P |